125
Views
30
CrossRef citations to date
0
Altmetric
Original Research

Anti-tumor effects of brucine immuno-nanoparticles on hepatocellular carcinoma

, , , , , , , , , , & show all
Pages 369-379 | Published online: 23 Jan 2012

References

  • ParkinDMBrayFFerlayJPisaniPGlobal cancer statistics, 2002CA Cancer J Clin20055527410815761078
  • TangZYYeSLLiuYKA decade’s studies on metastasis of hepatocellular carcinomaJ Cancer Res Clin Oncol2004130418719614685850
  • MitsunobuMToyosakaAOriyamaTOkamotoENakaoNIntrahepatic metastases in hepatocellular carcinoma: the role of the portal vein as an efferent vesselClin Exp Metastasis19961465205298970582
  • WuMCChenHZhangXHYaoXPYangJMSurgical treatment of primary liver cancer: 1102 casesAcad J Sec Mil Med Univ1993143201204
  • BelghitiJHiramatsuKBenoistSMassaultPSauvanetAFargesOSeven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resectionJ Am Coll Surg20001911384610898182
  • ZiserAPlevakDJWeisnerRHRakelaJOffordKPBrownDLMorbidity and mortality in cirrhotic patients undergoing anesthesia and surgeryAnesthesiology199990142539915311
  • CalneRYamanoiAOuraSKawamuraMLiver transplantation for hepatocarcinomaSurg Today1993231138384905
  • TangZYThe meaning and approach to carry out liver metastasis and recurrence researchChin J Gen Surg20062111761
  • ThomasMBZhuAXHepatocellular carcinoma: The need for progressJ Clin Oncol200523132892289915860847
  • WuMCSurgical treatment of primary liver cancerChin J Gen Surg20093413
  • QinJMXuXJShengXThe effect of brucine on hepatocellular carcinoma cell lines in vitroChin J Gen Surg2011263219221
  • DengXKCaiBCLvXYAnti-tumor effects comparision of the brucine and its liposomes in transplanted tumor-bearing miceJ Herb Med2006373389393
  • DengXKCaiBCYinWZhangXCLiWDSunQBrucine on mouse tumor inhibitionChin J Nat Med200536392396
  • DengXKCaiBCYinWLiuTSSunQLiWDResearch of the anti-tumor effect and toxicity of brucine in Heps tumor-bearing miceChin Pharmacol Bulletin20062213539
  • QinJMZhangYDWangHYWuMCNanotechnologies in the diagnosis and treatment of liver diseaseChin J Hepatobiliary Surg2004109646648
  • WangYLiQFengNPTanshinone IIA nanoparticles in the treatment of mouse liver cancer and its effects on Cyclin E expressionShanghai Traditional Chin Med2007417477
  • TorchilinVPDrug targetingEur J Pharm Sci200011Suppl 2S819111033430
  • DavdaJLabhasetwarVCharacterization of nanoparticle uptake by endothelial cellsInt J Pharm20022331–2515911897410
  • SahooSKPanyamJPrabhaSLabhasetwarVResidual polyvinylalcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptakeJ Control Release200282110511412106981
  • PanyamJLabhasetwarVDynamics of endocytosis and exocytosis of poly (D,L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cellsPharm Res200320221222012636159
  • LynchIAre there generic mechanisms governing interactions between nanoparticles and cells? Epitope mapping the other layer of the protein– material interfacePhysica A20073733511520
  • RowlandRESTaylorPWFlorenceATAttachment, uptake and transport of nanoparticles coated with an internal in A fragment in Caco-2 cell monolayerJ Drug Deliv Sci Technol2005153313317
  • WuJNantzMHZernMATargeting hepatocytes for drug and gene delivery: emerging novel approaches and applicationsFrontiers in Bioscience200271717725
  • LiuXBCaiMYPreparation and immunological identification of nanoparticles against human hepatocellular carcinoma in vitroChin J Immunology2000165262265
  • ChenYTangRHuangWStudy of hepatoma-specific immunal phospholipids doxorubicin nanoparticlesChin Pharmacist2002512712714
  • HuKQKyuloNLLimNElhazinBHillebrandDJBockTClinical significance of elevated alpha fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinomaAm J Gastroenterol200499586086515128351
  • MontaserLMAbbasOMSaltahAMWakedIACirculating AFP mRNA as a possible indicator of hematogenous spread of HCC cells: a possible association with HBV infectionJ Egypt Natl Canc Inst2007191486018839035
  • KamiyamaTTakahashiMNakagawaTAFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinomaAnn Surg2006244345146316926571
  • van der HeidenPLJedemaIWillemzeRBargeRMEfficacy and toxicity of gemtuzumab ozogamicin in patients with acute myeloid leukemiaEur J Haematol200676540941316480432
  • AdamsGPWeinerLMMonoclonal antibody therapy of cancerNat Biotechnol20052391147115716151408
  • WuAMSenterPDArming antibodies: prospects and challenges for immunoconjugatesNat Biotechnol20052391137114616151407
  • JhaRKMaQChenSShaHDingSRelationship of fibronectin and CD44v6 expression with invasive growth and metastasis of liver cancerCancer Invest200927332432819194823
  • SunHLiuGTInhibitory effect of anti-hepatitis drug bicyclol on invasion of human hepatocellular carcinoma MHCC97-H cells with high metastasis potential and its relative mechanismsJ Asian Nat Prod Res200911657658320183293
  • Garmy-SudiniBAvraamidesCJSchmidMCIntegrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasisCancer Res20107083042305120388801
  • JanikMELitynskaAVereeckenPCell migration – the role of integrin glycosylation DBiochim Biophys Acta20101800654555520332015
  • KruegelJMiosgeNBasement membrane components are key players in specialized extracellular matricesCell Mol Life Sci201067172879289520428923
  • WiradjajaFDiTommasoTSmythIBasement membranes in development and diseaseBirth Defects Res C Embryo Today201090183120301220
  • EscaffSFernándezJMGonzálezLOStudy of matrix metalloproteinases and their inhibitors in prostate cancerBr J Cancer2010102592292920160732